A synthetic peptide developed in Russia as an analog of tuftsin, a naturally occurring immune-regulating peptide found in the heavy chain of immunoglobulin G. Selank was approved in Russia in 2009 as a prescription nasal spray for generalized anxiety disorder and neurasthenia, making it one of the few peptides with actual regulatory approval as an anxiolytic. It's primarily used for anxiety reduction, cognitive enhancement, and mood stabilization.
The reason Selank gets attention over conventional anxiolytics is because it produces anti-anxiety effects comparable to benzodiazepines without sedation, cognitive impairment, tolerance, dependence, or withdrawal. If you're dealing with anxiety, stress-related brain fog, attention issues, or just want sharper cognition under pressure, Selank is worth understanding. It's also become a go-to for situational anxiety, things like public speaking, presentations, interviews, and high-stakes social situations where you need to stay calm and sharp without feeling sedated or mentally blunted the way a benzo would. The fast onset via nasal spray makes it practical for dosing 15-30 minutes before a specific event. It's also relevant for anyone on compounds that affect mood or stress response, since it modulates the same neurotransmitter systems (GABA, serotonin, dopamine) that get disrupted under those conditions.
Selank works through several overlapping mechanisms. Its anxiolytic effects come primarily from allosteric modulation of GABA-A receptors, the same receptor system benzodiazepines target, but through a different binding mechanism. One study found that Selank caused significant changes in the expression of 45 genes involved in GABAergic neurotransmission within 1 hour of administration, and that these changes positively correlated with those produced by GABA itself. Clinical studies confirmed that its anxiolytic effect is comparable to classical benzodiazepines like diazepam and phenazepam, but without their characteristic side effects. When administered alongside diazepam under chronic stress conditions, Selank actually enhanced the anxiolytic effect, suggesting it may increase the affinity of benzodiazepines for GABA-A receptors.
Beyond GABA, Selank influences serotonin metabolism and dopamine transmission in the frontal cortex and striatum, contributing to mood stabilization, motivation, and executive function. It also increases brain-derived neurotrophic factor (BDNF) expression in the hippocampus, the protein responsible for neuron survival, synaptic plasticity, and memory formation. This BDNF effect is likely what drives the longer-term cognitive benefits people report after consistent use. Selank also inhibits enkephalin-degrading enzymes, raising levels of the body's own endogenous opioid peptides, which contributes to stress resilience and a general sense of wellbeing without producing opioid-like effects or dependence.
Because Selank is derived from tuftsin, it retains immunomodulatory properties. It modulates IL-6 expression, influences the Th1/Th2 cytokine balance, and enhances natural killer cell and phagocyte activity. This is relevant if you're immunocompromised, recovering from illness, or running immunosuppressive compounds. It's also been studied for antiviral properties, though the human data on that front is limited.
Most of the clinical research on Selank comes from Russian institutions. The English-language literature is growing but still relatively thin compared to more mainstream compounds. The human trials that do exist are promising, showing significant reductions in anxiety symptoms for generalized anxiety disorder and neurasthenia, with additional anti-asthenic (energy-boosting) effects. Animal studies are more extensive and consistently show anxiolytic, nootropic, antidepressant, and neuroprotective effects. There's no established sex-specific difference in Selank's mechanism of action, and women respond to it through the same GABAergic and serotonergic pathways. Given that women are statistically more likely to experience anxiety disorders and that hormonal fluctuations can amplify GABAergic sensitivity, Selank may actually be particularly relevant for women dealing with stress, anxiety, or cognitive fog, though direct female-specific clinical data is limited.
Dosage:
- Intranasal (most studied route, original approved formulation): 200-400 mcg per session, 2-3 times daily. The Russian-approved formulation is a 0.15% solution, typically 2-3 sprays per nostril per session. Morning dosing is ideal to capture the nootropic benefits during the day
- Subcutaneous injection: 250-500 mcg once daily. Start at 250 mcg and titrate up based on response. Subcutaneous bypasses the nasal mucosa and likely provides higher bioavailability, so doses don't need to be as high as some protocols suggest
- Cycle length: 2-4 weeks on, 2-4 weeks off. Russian clinical trials typically used 14-day treatment courses. Some people extend to 4 weeks at lower doses without issues. No evidence of tolerance, dependence, or withdrawal, so the cycling is more about maintaining receptor sensitivity than managing addiction risk
- Onset: Effects can be noticeable within minutes to hours, particularly anxiolytic effects via nasal spray. Full cognitive and mood-stabilizing benefits typically develop over 7-14 days of consistent use
- No female-specific dose adjustment needed. Same dosing applies. Women on hormonal contraception or in high-stress phases may find Selank particularly effective due to the interaction between estrogen, progesterone, and GABAergic sensitivity
- Stacking: Selank is commonly stacked with Semax (a related Russian nootropic peptide). They work through complementary pathways, Selank providing the anxiolytic and calming effects while Semax adds cognitive stimulation and additional BDNF upregulation. Can also be taken alongside SSRIs or other anxiolytics under medical supervision, and may reduce some of their side effects
- Storage: Lyophilized powder should be stored frozen at -20°C. Once reconstituted, refrigerate at 2-8°C and use within 28 days. Pre-mixed nasal sprays must be cold-shipped and refrigerated
Here's what you can expect:
Selank works from the first dose. Most people feel a noticeable reduction in anxiety and an improvement in mental clarity within 15-30 minutes. It's not subtle in the way most peptides are, you'll likely feel calmer, more focused, and less reactive to stress the same day you start. This is one of the reasons it works so well for acute situations like public speaking or high-pressure meetings, you can dose before the event and feel the effect in real time.
The anxiolytic effects don't need to build up over weeks the way an SSRI would. Each dose produces its own effect. That said, with consistent daily use over 1-2 weeks, many people report that the baseline improvements in mood stability, stress resilience, and cognitive sharpness become more pronounced and sustained. The BDNF upregulation and serotonin modulation likely contribute to these longer-term benefits, but the core experience is immediate.
The immunomodulatory effects (reduced inflammation, improved immune function) are less outwardly noticeable and do develop more gradually over consistent use. But the main reason most people reach for Selank, the anxiety relief and cognitive clarity, is there from day one.
Side effects & risks:
- Very well tolerated overall. The safety profile is one of Selank's main advantages over conventional anxiolytics. No sedation, no dependence, no tolerance, no withdrawal, no cognitive impairment
- Nasal irritation is the most commonly reported side effect with intranasal use, usually mild and temporary
- Mild headache, fatigue, or dizziness reported occasionally, typically at higher doses or during the first few days of use. Usually resolves on its own
- Injection site reactions (redness, mild irritation) with subcutaneous administration, standard for any peptide injection. Rotate sites to minimize
- Immunogenicity risk: The FDA has flagged that compounded Selank may pose a risk for immunogenicity, where the body perceives the peptide as a threat and mounts an immune response. This risk is more relevant with injectable forms and poor-quality compounding. Source from reputable providers with third-party testing and certificates of analysis
- Drug interactions: Because Selank modulates GABA, serotonin, and dopamine, there's a theoretical interaction risk with medications that affect these same systems (SSRIs, benzodiazepines, antipsychotics). In practice, the available evidence suggests Selank may actually complement these medications rather than conflict with them, but use caution and discuss with a provider if you're on CNS-active medications
- Not enough long-term safety data in English-language literature. Most clinical trials were 14 days. Longer-term use appears safe based on clinical experience but formal data is limited
- Contraindications: Pregnancy, breastfeeding, active cancer (as a precaution given immunomodulatory effects), and anyone with autoimmune conditions should discuss with their provider first given Selank's effects on cytokine balance
Selank is not FDA-approved and is classified as a research chemical in the US. In Russia it is an approved prescription medication.
Made with Bullet